Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor

Cancer Research

Volumn 60, Issue 15, 2000, Pages 4194-4199

  Krebs, L J ^a   Wang, X ^a   Pudavar, H E ^a   Bergey, E J ^a   Schally, A V ^a   Nagy, A ^a   Prasad, P N ^a   Liebow, C ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN DERIVATIVE; EPIDERMAL GROWTH FACTOR; GONADORELIN DERIVATIVE; GONADORELIN RECEPTOR; GONADORELIN[6 DEXTRO LYSINE] 2 PYRROLINODOXORUBICIN; GONADORELIN[6 DEXTRO LYSINE] DOXORUBICIN; RC 166; UNCLASSIFIED DRUG; VAPREOTIDE;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CYTOTOXICITY; DRUG EFFICACY; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; SCANNING ELECTRON MICROSCOPY;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL MEMBRANE; CELL NUCLEUS; CYTOPLASM; DOXORUBICIN; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; EPIDERMAL GROWTH FACTOR; FLUORESCENT DYES; GONADOTROPIN-RELEASING HORMONE; HUMANS; MICROSCOPY, FLUORESCENCE; RECEPTORS, LHRH; SOMATOSTATIN; TUMOR CELLS, CULTURED;

EID: 0033901327     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors
2. Cytotoxic analogs of luteinizing hormone releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent
3. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines
4. Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer
5. Characteristics and distribution of receptors for [DTRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer
6. Inhibition of growth of OV-1063 human epithelial ovarian xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75
7. The use of luteinizing hormone-releasing hormone agonists in gynecological cancer
8. High affinity binding and direct antiproliferative effects of LHRH analogs in human ovarian cancer cell lines
9. The effects of gonadotropin-releasing hormone analogs in prostate cancer are mediated through specific tumor receptors
10. High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers
11. Membrane receptors for peptides in experimental and human pancreatic cancers
12. LH-RH receptors in the human pancreas: Basis for antihormonal treatment in ductal carcinoma of the pancreas
13. Growth inhibition of human ovarian cancers by cytotoxic analogs of luteinizing hormone-releasing hormone
14. Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers
15. Alterations in receptor-mediated kinases and phosphatases during carcinogenesis
16. Regulation of luteinizing hormone releasing hormone receptor binding by heterologous and autologous receptor-stimulated tyrosine phosphorylation
17. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors
18. Solubilization of a large molecular weight form of the rat LHRH receptor
19. Chemically labeled new cytotoxic agent: Two-photon fluorophore for optical tracking of cellular pathway in chemotherapy
20. New sulfonyl-containing materials for nonlinear optics: Semi-empirical calculations, synthesis, and properties
21. Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability
22. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing
23. Two-photon laser scanning fluorescence microscopy
24. Two-photon molecular excitation provides intrinsic 3-dimensional resolution for laser-based microscopy and microphotochemistry
25. Synergistic effects of bombesin and epidermal growth factor on cancers
26. Octreotide acetate (Sandostatin, SMS) increases in vitro accumulation of doxorubicin (DOX)
27. Potentiation of the anti-proliferative effects of anti-cancer drugs by octreotide in vitro and in vivo
28. A critical evaluation of the mechanisms of the action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin